SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-454778
Filing Date
2012-11-06
Accepted
2012-11-06 17:03:48
Documents
10
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d398335d10q.htm 10-Q 641854
2 EX-31.1 d398335dex311.htm EX-31.1 6023
3 EX-31.2 d398335dex312.htm EX-31.2 6007
4 EX-32.1 d398335dex321.htm EX-32.1 4668
  Complete submission text file 0001193125-12-454778.txt   3793593

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT acrx-20120930.xml EX-101.INS 515158
6 XBRL TAXONOMY EXTENSION SCHEMA acrx-20120930.xsd EX-101.SCH 36947
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acrx-20120930_cal.xml EX-101.CAL 39558
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acrx-20120930_def.xml EX-101.DEF 141219
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE acrx-20120930_lab.xml EX-101.LAB 278541
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acrx-20120930_pre.xml EX-101.PRE 200806
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35068 | Film No.: 121183965
SIC: 2834 Pharmaceutical Preparations